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Abstract
The association of pseudo-Meigs’ syndrome, elevation of CA 125 to the struma ovarii is a rare condition. So far only
nine cases have been reported in English literature through MEDLINE search. Here we report a 46-year-old case of
the struma ovarii, presented with ascites, hydrothorax, right ovarian mass and elevated serum CA 125 level. These
findings were misdiagnosed for an ovarian malignancy at the first impression. Immediate resolution of the ascites,
hydrothorax and normalization of the serum CA 125 level were followed by ovarian mass removal. Struma ovarii
could be a rare cause of ascites, hydrothorax, ovarian mass and elevated CA 125. This rare condition should be
considered in the differential diagnosis in patents with ascites and pleural effusions but with negative cytology.
Background
Struma ovarii is a rare ovarian neoplasm derived from
germ cells in a mature teratoma. This tumor is generally
benign, although malignant transformation has been
reported [1]. The preoperative diagnosis is generally dif-
ficult. Thyroid hormones may be produced and in a few
cases asymptomatic women may develop definitive clini-
cal hypothyroidism after resection of struma ovarii. We
here report an unusual case of a 46-year-old woman
presented with ascites, right ovarian mass, and elevated
CA 125 level, which was suspicious for an ovarian
malignancy and underwent a total hysterectomy and
bilateral salpingo-oophorectomy. The pathologic diagno-
sis was struma ovarii, a specialized ovarian teratoma
composed predominantly of mature thyroid tissue. The
postoperative period was uneventful and her thyroid
function was normal. We had reviewed the related lit-
eratures in this report as well.
Case presentation
The present case is a 46-year-old, female, gravida 1, para
1, who was admitted to a local hospital, complaining of
fatigue, anorexia, and abdominal swelling. Her medical
history included nothing special. Physical examination
revealed a palpable mass in the lower abdomen. A thor-
acoabdominal CT scan showed marked pleural effusion
and a heterogeneous mass, large ascites with many nod-
osity images in the pelvic wall and considered as malig-
nant tumor of ovary.
She was then transferred to our hospital for further
treatment in September, 2009. The patient’ss e r u mC A
125 level was 1230.9 U/mL, while CEA (2.6 ng/ml), AFP
(14.2 ng/ml), CA 199 (14.8 U/ml), and CA 153 (7.8 U/ml)
levels were within the normal range. Abdominal ultraso-
nography showed a heterogeneous, multiloculated mass,
with a moderate amount of ascites, and subsequent trans-
vaginal ultrasonography revealed a large complex pelvic
mass, 16 cm largest dimension, of probable adnexal origin
with low blood resistance flow within the tumor. The
uterus was normal in size. Abdominal paracentesis yielded
2 liters of yellow serous fluid consistent with an exudative
process. Microscopy and cytology revealed only reactive
mesothelial cells without malignant cells.
The patient was arranged for an exploratory laparot-
omy. Six liters of straw-colored ascites was evacuated.
The uterus was in normal size and the left ovary mea-
sured 3 × 2 × 2 cm with a normal appearance. A 20 ×
18 × 15 cm complex, multicystic mass, without evidence
of external excrescences, had replaced the right ovary.
There was no evidence of intraperitoneal (ie. omenta,
the surface of convolutions, appendix, liver, etc) spread
of disease or retroperitoneal adenopathy. And right
* Correspondence: xinludoc@163.com; xucj@hotmail.com
Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan
University, Shanghai, P.R. China
Jiang et al. Journal of Ovarian Research 2010, 3:18
http://www.ovarianresearch.com/content/3/1/18
© 2010 Jiang et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.salpingo-oophorectomy was performed. A frozen section
of the right ovarian mass was interpreted as struma
ovarii. As strongly insisted by the patient and her family
member, a subsequent hysterectomy and left salpingo-
oophorectomy were performed according to the
informed consent.
Post operative thyroid function test including serum
levels of TT3 (1.78 nmo1/L), TT4 (82.5 nmo1/L), FT3
(8.2 pmol/L), FT4 (30.5 pmol/L) and TSH (2.3 mU/ml)
were performed on day two, which were within normal
limits. The level of CA 125 was decreased to 817 U/mL.
The final pathology revealed right struma ovarii with
benign thyroid tissue confined to the ovary (Figure 1).
The uterus, left ovary, fallopian tube were histologically
unremarkable and the cytologic evaluation of the ascitic
fluid showed no evidence of malignant cells.
The patient recovered uneventfully and was dis-
charged home on the ninth postoperative day with a CA
125 level of 485 U/mL. Following up three months after
her surgery, she had no evidence of ascites and the
serum levels of CA 125 was in normal range, she was
symptomatically much improved from her preoperative
condition and received hormone replacement therapy.
Discussion
Mature cystic teratomas account for approximately 20%
of all ovarian tumors. Of these, approximately 15% con-
tain normal thyroid tissue. Struma ovarii is a monoder-
mal variant of ovarian teratoma, which predominantly
contains thyroid tissue (greater than 50%) and was first
described by Von Klden in 1895 and Gottschalk in 1899
[2]. It constitutes about 2.7% of ovarian teratomas. It is
usually a benign condition although occasionally, malig-
nant transformation is observed. Preoperative clinical
diagnosis of struma ovarii, however, is very difficult.
Despite containing thyroid tissue, only 5% of struma
ovarii have features of hyperthyroidism [3]. Ascites has
been reported in one-third of cases [2]. However,
uncommon is the association of ascites and hydrothorax
with this tumor [2]. Meigs first described the syndrome
consisting of ovarian fibroma/thecoma, with ascites and
hydrothorax, characterized by the resolution of symp-
toms with removal of the benign tumor [2]. Meigs’ syn-
drome proposed to benign and solid tumors with the
gross appearance of a fibroma (fibroma, thecoma, granu-
losa cell tumor), accompanied by ascites and hydro-
thorax. While similar clinic manifestations presented in
other conditions was termed as pseudo-Meigs syn-
drome. The ascitic and pleural fluids in Meigs’ and
pseudo-Meigs’ syndrome are usually serous, but may be
serosanguinous. The origin of the effusions remains
obscure, although some mechanisms have been sug-
gested such as active fluid secretion by the tumor or
peritoneum, venous and/or lymphatic obstruction, low
serum protein and inflammatory products [4].
In the literature, very few reports have been published
on struma ovarii associated to ascites and elevated
CA125 [5-8]. In both cases, patients presented with
Figure 1 Microscopic appearance of the right ovary showing thyroid follicles of varying sizes. (H & E, 100×).
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of the English language literature provides only nine case
report describing struma ovarii presenting as pseudo-
Meigs’ syndrome with an elevated CA 125 level can initi-
ally suggest ovarian carcinoma [9-16]. (Table 1) We
describe an additional case to the tenth reported in the
literature with struma ovarii associated with pseudo-
Meigs syndrome and elevated CA 125, which shows ana-
logies with the ones reported in the literature. It differs in
some important respects. Firstly the patient’sa g e ,t h i si s
much younger than that when the majority of these
tumors occur i.e. in the fifties. Secondly, the patient
underwent a wide resection operation because of the
strong desire of both the patient and her husband and
received a hormone replacement therapy subsequently.
T h ee l e v a t i o no fC A1 2 5m a yh a v eb e e ns e c o n d a r yt o
t h ep r e s e n c eo fa s c i t e s ;h owever, its level was much
higher than that typically seen with ascites of benign
origin. An ovarian mass with ascites and elevated serum
CA 125 level in a woman generally suggest a malignancy
process. So the present case with the clinic findings of
ascites, hydrothorax, markedly elevated serum CA 125
and a large complex pelvic mass in a woman strongly
suggest pelvic malignancy before operation. But com-
plete remission of the ascites, hydrothorax, and CA125
was obtained after surgery without any adjuvant therapy.
Conclusion
This report emphasizes that there are benign gynecolo-
gical conditions might show clinical, ultrasonographic
and biochemical signs suggestive of malignancy. They
rarely should be considered as the benign diseases in
the differential diagnosis when the patients presented
with ascites, elevated serum CA 125 and pleural effu-
sions, but with negative cytologic examination.
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